{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:17:05Z","timestamp":1790471825953,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray<jats:sup>\u00ae<\/jats:sup> PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14\u00a0days.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12941-020-00358-y","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T10:27:08Z","timestamp":1587724028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin"],"prefix":"10.1186","volume":"19","author":[{"given":"Jos\u00e9","family":"Mill\u00e1n-O\u00f1ate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alfonso","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Guillermo","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Fernandez-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Katterine","family":"Bonilla-Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso J.","family":"Rodr\u00edguez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"358_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101613","author":"AJ Rodriguez-Morales","year":"2020","unstructured":"Rodriguez-Morales AJ, Gallego V, Escalera-Antezana JP, Mendez CA, Zambrano LI, Franco-Paredes C, Suarez JA, Rodriguez-Enciso HD, Balbin-Ramon GJ, Savio-Larriera E, et al. COVID-19 in Latin America: the implications of the first confirmed case in Brazil. Travel Med Infect Dis. 2020. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101613.","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"358_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.35663\/amp.2020.371.909","volume":"37","author":"AJ Rodriguez-Morales","year":"2020","unstructured":"Rodriguez-Morales AJ, S\u00e1nchez-Duque JA, Hern\u00e1ndez-Botero S, P\u00e9rez-D\u00edaz CE, Villamil-G\u00f3mez WE, M\u00e9ndez CA, Verbanaz S, Cimerman S, Rodriguez-Enciso HD, Escalera-Antezana JP, et al. Preparaci\u00f3n y control de la enfermedad por coronavirus 2019 (COVID-19) en Am\u00e9rica Latina. Acta Medica Peruana. 2020;37(1):3\u20137.","journal-title":"Acta Medica Peruana"},{"key":"358_CR3","doi-asserted-by":"publisher","first-page":"101604","DOI":"10.1016\/j.tmaid.2020.101604","volume":"2020","author":"V Gallego","year":"2020","unstructured":"Gallego V, Nishiura H, Sah R, Rodriguez-Morales AJ. The COVID-19 outbreak and implications for the Tokyo 2020 Summer Olympic Games. Travel Med Infect Dis. 2020;2020:101604.","journal-title":"Travel Med Infect Dis"},{"issue":"3","key":"358_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.22354\/in.v24i3.848","volume":"24","author":"J Millan-O\u00f1ate","year":"2020","unstructured":"Millan-O\u00f1ate J, Rodr\u00edguez-Morales AJ, Camacho-Moreno G, Mendoza-Ram\u00edrez H, Rodr\u00edguez-Sabogal IA, \u00c1lvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19). Infection. 2020;24(3):187\u201392.","journal-title":"Infection"},{"key":"358_CR5","unstructured":"Coronavirus (COVID-19) en Colombia. https:\/\/www.ins.gov.co\/Noticias\/Paginas\/Coronavirus.aspx."},{"key":"358_CR6","unstructured":"Novel coronavirus\u2014prevention & treatment. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/about\/prevention-treatment.html."},{"key":"358_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.03.005","author":"A Cortegiani","year":"2020","unstructured":"Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020. https:\/\/doi.org\/10.1016\/j.jcrc.2020.03.005.","journal-title":"J Crit Care"},{"key":"358_CR8","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01047","author":"J Gao","year":"2020","unstructured":"Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020. https:\/\/doi.org\/10.5582\/bst.2020.01047.","journal-title":"Biosci Trends"},{"key":"358_CR9","unstructured":"Coronavirus disease 2019 (COVID-19). UpToDate. https:\/\/www.uptodate.com\/contents\/coronavirus-disease-2019-covid-19."},{"key":"358_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1142\/S0192415X20500378","volume":"2020","author":"KW Chan","year":"2020","unstructured":"Chan KW, Wong VT, Tang SCW. COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative chinese-western medicine for the management of 2019 novel coronavirus disease. Am J Chin Med. 2020;2020:1\u201326.","journal-title":"Am J Chin Med"},{"issue":"1","key":"358_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/22221751.2020.1735265","volume":"9","author":"T Li","year":"2020","unstructured":"Li T. Diagnosis and clinical management of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0). Emerg Microbes Infect. 2020;9(1):582\u20135.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"358_CR12","first-page":"11","volume":"7","author":"YR Guo","year":"2020","unstructured":"Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2014an update on the status. Mil Med Res. 2020;7(1):11.","journal-title":"Mil Med Res"},{"key":"358_CR13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2001282.","journal-title":"N Engl J Med"},{"issue":"396","key":"358_CR14","doi-asserted-by":"publisher","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","volume":"9","author":"TP Sheahan","year":"2017","unstructured":"Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017;9(396):eaal3653.","journal-title":"Sci Transl Med"},{"issue":"3","key":"358_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269\u201371.","journal-title":"Cell Res"},{"key":"358_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237","author":"X Yao","year":"2020","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa237.","journal-title":"Clin Infect Dis"},{"key":"358_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105932","author":"P Colson","year":"2020","unstructured":"Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105932.","journal-title":"Int J Antimicrob Agents"},{"key":"358_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105938","author":"CA Devaux","year":"2020","unstructured":"Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105938.","journal-title":"Int J Antimicrob Agents"},{"key":"358_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105945","author":"Z Sahraei","year":"2020","unstructured":"Sahraei Z, Shabani M, Shokouhi S, Saffaei A. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine. Int J Antimicrob Agents. 2020. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105945.","journal-title":"Int J Antimicrob Agents"},{"key":"358_CR20","doi-asserted-by":"publisher","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","volume":"177","author":"F Touret","year":"2020","unstructured":"Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antiviral Res. 2020;177:104762.","journal-title":"Antiviral Res"},{"issue":"1","key":"358_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1148\/radiol.2020200269","volume":"295","author":"H Shi","year":"2020","unstructured":"Shi H, Han X, Zheng C. Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan, China. Radiology. 2020;295(1):20.","journal-title":"Radiology"},{"key":"358_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15869","author":"L Zhu","year":"2020","unstructured":"Zhu L, Xu X, Ma K, Yang J, Guan H, Chen S, Chen Z, Chen G. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant. 2020. https:\/\/doi.org\/10.1111\/ajt.15869.","journal-title":"Am J Transplant"},{"key":"358_CR23","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","author":"VM Corman","year":"2020","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Brunink S, Schneider J, Schmidt ML, et al. Detection of novel 2019 coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.3.2000045.","journal-title":"Euro Surveill"},{"key":"358_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1.","journal-title":"Lancet Infect Dis"},{"key":"358_CR25","doi-asserted-by":"publisher","first-page":"m751","DOI":"10.1136\/bmj.m751","volume":"368","author":"M Day","year":"2020","unstructured":"Day M. Covid-19: surge in cases in Italy and South Korea makes pandemic look more likely. BMJ. 2020;368:m751.","journal-title":"BMJ"},{"issue":"2","key":"358_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3855\/jidc.12600","volume":"14","author":"R Porcheddu","year":"2020","unstructured":"Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19\/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020;14(2):125\u20138.","journal-title":"J Infect Dev Ctries"},{"issue":"5","key":"358_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jmv.25699","volume":"92","author":"M Giovanetti","year":"2020","unstructured":"Giovanetti M, Benvenuto D, Angeletti S, Ciccozzi M. The first two cases of 2019-nCoV in Italy: where they come from? J Med Virol. 2020;92(5):518\u201321.","journal-title":"J Med Virol"},{"key":"358_CR28","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.9.2000178","author":"G Spiteri","year":"2020","unstructured":"Spiteri G, Fielding J, Diercke M, Campese C, Enouf V, Gaymard A, Bella A, Sognamiglio P, Sierra Moros MJ, Riutort AN, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 2020. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.9.2000178.","journal-title":"Euro Surveill"},{"key":"358_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30060-8","author":"H Legido-Quigley","year":"2020","unstructured":"Legido-Quigley H, Mateos-Garcia JT, Campos VR, Gea-Sanchez M, Muntaner C, McKee M. The resilience of the Spanish health system against the COVID-19 pandemic. Lancet Public Health. 2020. https:\/\/doi.org\/10.1016\/S2468-2667(20)30060-8.","journal-title":"Lancet Public Health"},{"issue":"10223","key":"358_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514\u201323.","journal-title":"Lancet"},{"issue":"10223","key":"358_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet"},{"issue":"10223","key":"358_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"10","key":"358_CR33","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","volume":"382","author":"ML Holshue","year":"2020","unstructured":"Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929\u201336.","journal-title":"N Engl J Med"},{"issue":"8","key":"358_CR34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMp2000929","volume":"382","author":"VJ Munster","year":"2020","unstructured":"Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China\u2014key questions for impact assessment. N Engl J Med. 2020;382(8):692\u20134.","journal-title":"N Engl J Med"},{"issue":"8","key":"358_CR35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333.","journal-title":"N Engl J Med"},{"key":"358_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101623","author":"AJ Rodriguez-Morales","year":"2020","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101623.","journal-title":"Travel Med Infect Dis"},{"key":"358_CR37","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.23034","author":"S Salehi","year":"2020","unstructured":"Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. AJR Am J Roentgenol. 2020. https:\/\/doi.org\/10.2214\/AJR.20.23034.","journal-title":"AJR Am J Roentgenol"},{"issue":"S3","key":"358_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22354\/in.v24i3.851","volume":"24","author":"CHS Trujillo","year":"2020","unstructured":"Trujillo CHS. Consenso colombiano de atenci\u00f3n, diagn\u00f3stico y manejo de la infecci\u00f3n por SARS-COV-2\/COVID-19 en establecimientos de atenci\u00f3n de la salud - Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(S3):1\u2013102.","journal-title":"Infectio"},{"key":"358_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa114","author":"D Zhou","year":"2020","unstructured":"Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020. https:\/\/doi.org\/10.1093\/jac\/dkaa114.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"358_CR40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3899\/jrheum.161063","volume":"44","author":"A Srinivasa","year":"2017","unstructured":"Srinivasa A, Tosounidou S, Gordon C. Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand-related issue? J Rheumatol. 2017;44(3):398.","journal-title":"J Rheumatol"},{"key":"358_CR41","unstructured":"Clinical Trials Registry\u2014chloroquine COVID-19. https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=COVID-19&term=Chloroquine&cntry=&state=&city=&dist=."},{"key":"358_CR42","unstructured":"Interim clinical guidance for patients suspected of\/confirmed with COVID-19 in Belgium. https:\/\/epidemio.wiv-isp.be\/ID\/Documents\/Covid19\/COVID-19_InterimGuidelines_Treatment_ENG.pdf."},{"issue":"3","key":"358_CR43","first-page":"185","volume":"43","author":"Multicenter collaboration group of Department of S","year":"2020","unstructured":"Multicenter collaboration group of Department of S, Technology of Guangdong P, Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus p. Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(3):185\u20138.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"358_CR44","unstructured":"Coronavirus Disease 2019 (COVID-19) treatment & management. https:\/\/emedicine.medscape.com\/article\/2500114-treatment."},{"key":"358_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105960","author":"J Fantini","year":"2020","unstructured":"Fantini J, Scala CD, Chahinian H, Yahi N. Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob Agents. 2020. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105960.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"358_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2307\/30147135","volume":"13","author":"MS Whitman","year":"1992","unstructured":"Whitman MS, Tunkel AR. Azithromycin and clarithromycin: overview and comparison with erythromycin. Infect Control Hosp Epidemiol. 1992;13(6):357\u201368.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"358_CR47","unstructured":"Information for clinicians on therapeutic options for COVID-19 patients. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/therapeutic-options.html."},{"key":"358_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","author":"P Gautret","year":"2020","unstructured":"Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"358_CR49","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","volume":"323","author":"E Keyaerts","year":"2004","unstructured":"Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004;323(1):264\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"358_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69.","journal-title":"Virol J"},{"key":"358_CR51","doi-asserted-by":"publisher","first-page":"104591","DOI":"10.1016\/j.antiviral.2019.104591","volume":"171","author":"M Arikata","year":"2019","unstructured":"Arikata M, Itoh Y, Shichinohe S, Nakayama M, Ishigaki H, Kinoshita T, Le MQ, Kawaoka Y, Ogasawara K, Shimizu T. Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys. Antiviral Res. 2019;171:104591.","journal-title":"Antiviral Res"},{"issue":"5","key":"358_CR52","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.chest.2016.11.012","volume":"151","author":"IFN Hung","year":"2017","unstructured":"Hung IFN, To KKW, Chan JFW, Cheng VCC, Liu KSH, Tam A, Chan TC, Zhang AJ, Li P, Wong TL, et al. Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, Phase IIb\/III Trial. Chest. 2017;151(5):1069\u201380.","journal-title":"Chest"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-020-00358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-020-00358-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-020-00358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T23:10:25Z","timestamp":1619219425000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-020-00358-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1186\/s12941-020-00358-y","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written consent from the patient was obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent from the patient was obtained for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}